The Drexel University School of Public Health was awarded one of only eight Visiting Professorships in Diabetes from Pfizer this year. Dr. Frank Hu, MD, PhD, a professor of nutrition and epidemiology at Harvard University, gave the lecture, "Understanding the Complex Causes of Diabetes: Improving Guidance for Prevention and Management," on Wednesday, December 10 at the Geary A Auditorium of the New College Building. Click here for event flyer.
L-R: Gillian Black-Noller (Sr. Director, Pfizer Pharmaceuticals), Dr. Frank Hu,
Prof. Craig Newschaffer (Drexel School of Public Health)
Earlier in the week, Dr. Hu also led presentations, workshops and seminars, including:
Monday, December 8, 2008
Presentation and Workshop
Emerging topics in nutrition and obesity related to Diabetes research
Presentation: 1:30 pm - 2:30 pm
Workshop: 2:30 pm - 4:30 pm
Tuesday, December 9, 2008
Seminar
Approaching gene-environment interactions in complex chronic diseases
10:00 am - 12:00 pm
Dr. Hu is a nationally and internationally recognized researcher in nutrition and diabetes epidemiology. He has published more than 300 original papers and 30 review papers in major medical and nutrition journals. He has recently published a textbook on Obesity Epidemiology (Oxford University Press, 2008). Dr. Hu was trained in medicine in China.
He received his master and doctoral degrees in epidemiology at the University of Illinois at Chicago and completed his nutritional epidemiology fellowship at Harvard. Dr. Hu's research is based on both U.S. and Chinese populations. He has accumulated more than 10 years of experience in conducting collaborative research in China.
Dr. Hu's research has primarily focused on nutritional and lifestyle risk factors of obesity, type 2 diabetes and cardiovascular disease. He is the Principal Investigator of the diabetes component of the Nurses' Health Study. Dr. Hu is the recipient of an American Heart Association Established Investigator Award and an American Diabetes Association Research Award. Dr. Hu is on the editorial board of Diabetes Care, and has served on grant review panels for the NIH and American Diabetes Association.